Eckhard Thiel spends much of his time researching Internal medicine, Immunology, Surgery, Leukemia and Oncology. Eckhard Thiel regularly links together related areas like Gastroenterology in his Internal medicine studies. Immunology is frequently linked to Transplantation in his study.
His Transplantation study deals with Virology intersecting with Acquired immunodeficiency syndrome. The various areas that Eckhard Thiel examines in his Leukemia study include Myeloid, Cancer research, Myeloid leukemia and Haematopoiesis. His Oncology research includes themes of Lymphoblastic Leukemia, Anemia, White blood cell, Survival analysis and Bone marrow.
His primary scientific interests are in Internal medicine, Immunology, Cancer research, Oncology and Surgery. Much of his study explores Internal medicine relationship to Gastroenterology. As part of his studies on Immunology, Eckhard Thiel frequently links adjacent subjects like Cytotoxic T cell.
His study in Oncology is interdisciplinary in nature, drawing from both Cancer and Melanoma. His Chemotherapy study combines topics in areas such as Methotrexate and Radiation therapy. His Leukemia research is multidisciplinary, incorporating elements of Myeloid, Myeloid leukemia and Immunophenotyping.
His primary areas of study are Internal medicine, Immunology, Oncology, Transplantation and Surgery. His Internal medicine study frequently draws connections to other fields, such as Gastroenterology. His Immunology research is multidisciplinary, relying on both Cytotoxic T cell and BAALC.
His work deals with themes such as Cancer, Bioinformatics, Pathology, ThioTEPA and Survival analysis, which intersect with Oncology. His research integrates issues of Immunosuppression, Stem cell and Virology in his study of Transplantation. His work on Ifosfamide, Radiation therapy and Survival rate as part of his general Surgery study is frequently connected to In patient, thereby bridging the divide between different branches of science.
Eckhard Thiel mainly focuses on Internal medicine, Immunology, Transplantation, Leukemia and Oncology. His biological study spans a wide range of topics, including Gastroenterology and Surgery. His studies link Peripheral blood mononuclear cell with Immunology.
His Transplantation research incorporates elements of Stem cell, Immunopathology and Virology. His work carried out in the field of Leukemia brings together such families of science as Cancer research, Myeloid leukemia and Fms-Like Tyrosine Kinase 3. His Oncology research integrates issues from Randomized controlled trial, Multimodal therapy and Confidence interval.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett.
The New England Journal of Medicine (2002)
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
Gero Hütter;Daniel Nowak;Maximilian Mossner;Susanne Ganepola.
The New England Journal of Medicine (2009)
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
David W. Denning;Patricia Ribaud;Noel Milpied;Denis Caillot.
Clinical Infectious Diseases (2002)
Evidence for the cure of HIV infection by CCR5Δ32/Δ32 stem cell transplantation.
Kristina Allers;Gero Hütter;Jörg Hofmann;Christoph Loddenkemper.
Establishment of a human cell line (mono mac 6) with characteristics of mature monocytes
H. W. Löms Ziegler-Heitbroc;Eckhard Thiel;Agnes Futterer;Volker Herzog.
International Journal of Cancer (1988)
Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS Lymphoma
Lauren E. Abrey;Tracy T. Batchelor;Andrés J.M. Ferreri;Mary Gospodarowicz.
Journal of Clinical Oncology (2005)
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.
Monika Brüggemann;Thorsten Raff;Thomas Flohr;Nicola Gökbuget.
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
Eckhard Thiel;Agnieszka Korfel;Peter Martus;Lothar Kanz.
Lancet Oncology (2010)
Improved outcome in central nervous system aspergillosis, using voriconazole treatment.
Stefan Schwartz;Markus Ruhnke;Patricia Ribaud;Lawrence Corey.
Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study of the German Multicenter Trial Group and confirmed polymerase chain reaction analysis
Beate Gleißner;Nicola Gökbuget;Claus R. Bartram;Bart Janssen.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: